One Factory to Rule Them All: How Musk's Terafab Could Rewrite the Scale of U.S. Chip Production

Elon Musk outlined Terafab, a proposed 100 million-square-foot U.S. chip facility targeting 1 terawatt of annual output, or roughly 1 billion logic chips initially and 100 billion to 200 billion total chips at full scale. The project could theoretically double current U.S. chip production from a single Texas site, but Bernstein estimates the required capacity could cost $5 trillion to $13 trillion and would need dozens to hundreds of EUV tools. The announcement is strategically bullish for AI and semiconductor supply-chain buildout, but execution risks remain extremely high.

Analysis

The market is likely underappreciating that the bottleneck is not demand for chips but throughput for the enabling equipment stack. If the project moves from rhetoric to permitting and site selection, the first-order beneficiaries are the picks-and-shovels names with scarce, long-lead manufacturing tools, while the first-order losers are any single-node capacity overhang stories that depend on a still-cyclical foundry market. The second-order effect is that a credible domestic mega-fab would tighten the strategic value of U.S.-based supply chains, raising the option value of every adjacent localization theme from power infrastructure to specialty chemicals.

For TSM, the near-term impact is less about lost volume and more about narrative compression: a U.S.-anchored mega-fab weakens the “irreplaceable Taiwan capacity” premium at the margin, even if execution risk keeps that premium intact for years. Intel is the most obvious external beneficiary because even a marginal role in development, process transfer, or ecosystem capture can re-rate the stock on the possibility of being embedded in a government-aligned industrial policy stack. ASML is the cleanest tactical squeeze: the story implies a material increase in future EUV demand, but the market will immediately focus on shipment constraints and whether incremental tool availability can actually support the buildout; that scarcity can support the stock on every announcement, but also limits how fast the thesis can be monetized.

The contrarian view is that this is a capital-intensity fantasy unless power, water, labor, and tool supply are solved as an integrated system, not separately. The true gating item is time: initial headlines can move names over days to weeks, but the operational consequences are years out, and the market may be overpricing a straight-line ramp that never happens. If execution slips, the setup reverses quickly because the market will re-anchor on headline-grabbing ambition rather than cash flow reality, especially in the more expensive semiconductor equipment complex.

Key Decisions for Investors

• Short-dated tactical long ASML vs short TSM pair into any Terafab headline flow; risk/reward favors ASML because incremental EUV scarcity is the nearest monetizable bottleneck, while TSM faces subtle narrative pressure from U.S. onshoring over the next 3-12 months.
• Buy INTC on pullbacks as a 6-18 month policy/optionality trade; upside comes from any non-economic participation in a strategic domestic manufacturing ecosystem, while downside is capped by already-low expectations and asset-repositioning optionality.
• Sell upside in ASML on strength via call spreads if the stock gaps on Terafab headlines; implied move can outpace realizable order flow, and the thesis is vulnerable to actual tool delivery constraints over the next 2-4 quarters.
• For TSLA, treat this as a long-dated strategic call rather than a near-term earnings catalyst; consider small Jan-2027 call structures only if you want exposure to ecosystem integration, with thesis invalidation if project milestones slip beyond 12 months.
• Avoid chasing TSM weakness; if anything, use any selloff to add, because the market may overreact to a U.S. capacity narrative while Taiwan’s installed ecosystem and yield curve still dominate actual advanced-node economics.